News | May 02, 2014

Late-Breaking Trials to be Presented at SCAI Announced

Late-Breaking Trials SCAI May 2014

May 2, 2014 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the late-breaking clinic al trial data presentations for it its upcoming 2014 Scientific Sessions, May 28-31, in Las Vegas. The late-breaking clinical trials will be presented Friday, May 30, from 2-3 p.m. PST. These are:

• Effect of a Real Time Radiation Monitoring Device on Radiation Exposure During Cardiac Catheterization: The Radiation Reduction during Cardiac Catheterization Using Real Time Monitoring (RadiCure) Study, presented by Georgios Christopoulos, M.D.

• Diamondback 360° Coronary Orbital Atherectomy System for Treating De Novo, Severely Calcified Lesions: ORBIT II 1-Year Results and Cost Comparison to a Sample of Medicare Hospital Claims, presented by Jeffrey Chambers, M.D., FSCAI

• Comparison of Lesion Level Decision Making in the Cath Lab Using Hyperemic and Non-Hyperemic Pressure Wire Derived Indices of Stenosis Severity: The VERIFY-2 Study, presented by Stuart Watkins, M.D.

• 3-Dimensional Quantitative Coronary Angiography Using Coronary Catheters as Objective Markers Reliably Unmasks Severe Occult Stenosis in Diffusely Diseased Vessels: New Results from the IQ-CATEGORIZE Lesions Study, presented by Charles Laham, M.D., FSCAI

This year’s keynote speakers will discuss hot topics in interventional cardiology, including the challenges and opportunities today’s professionals face:

• Martin Leon, M.D., FSCAI, will focus on the evolution of innovation in interventional cardiology. Leon’s remarks will touch on the past and present of the field, but will emphasize the future of one of the most rapidly evolving, cutting-edge areas of medicine and the role of each professional in continuing to break new ground in ever-improving patient care.

• Pediatric interventional cardiologist James E. Lock, M.D., will address the obstacles involved in development of new and effective treatments for the littlest hearts, including clinical trial execution. Lock will discuss his step-by-step process for successful innovation amidst these challenges and will challenge the interventional cardiology community to innovate, offering kids the best chance to grow and thrive.  

• Patrick T. O’Gara, M.D., will explore the dynamic challenges facing the cardiovascular workforce, including restrictions to Medicare-based funding for residencies and the growing gap between the demand for cardiovascular specialists and the supply. O’Gara also will present practical solutions for interventional cardiologists and their practices to implement as the healthcare environment continues to evolve.

For more information: www.scai.org/SCAI2014


Related Content

News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

Home April 08, 2024
Home
Subscribe Now